Citations for
1FLT1
Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
Hammadah M, Georgiopoulou VV, Kalogeropoulos AP, Weber M, Wang X, Samara MA, Wu Y, Butler J, Tang WH.
Circ Heart Fail 9(1):e002115. doi: 10.1161/CIRCHEARTFAILURE.115.002115. Epub 2015 Dec 23. 2016
2EPO, EPOR, FLT1
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A, Hermanowicz J, Surażynski A, Rożkiewicz D, Pryczynicz A, Domaniewski T, Pawlak K, Kemona A, Pawlak D.
Mol Cell Biochem 421(1-2):1-18. doi: 10.1007/s11010-016-2779-x. Epub 2016 Aug 20. 2016
3FLT1, JMJD6
Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
Palmer KR, Tong S, Tuohey L, Cannon P, Ye L, Hannan NJ, Brownfoot FC, Illanes SE, Kaitu'u-Lino TJ.
Biol Reprod 94(3):59. doi: 10.1095/biolreprod.115.134460. Epub 2016 Jan 27. 2016
4FLT1, PGF
Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
Gurnadi JI, Mose J, Handono B, Satari MH, Anwar AD, Fauziah PN, Yogi Pramatirta A, Rihibiha DD.
BMC Res Notes 8:534. doi: 10.1186/s13104-015-1506-0. 2015
5FLT1
A Role of sFlt-1 in Oxidative Stress and Apoptosis in Human and Mouse Pre-Eclamptic Trophoblasts.
Jiang Z, Zou Y, Ge Z, Zuo Q, Huang SY, Sun L.
Biol Reprod 93(3):73. doi: 10.1095/biolreprod.114.126227. Epub 2015 Jul 22. 2015
6FLT1
A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain.
Selvaraj D, Gangadharan V, Michalski CW, Kurejova M, Stösser S, Srivastava K, Schweizerhof M, Waltenberger J, Ferrara N, Heppenstall P, Shibuya M, Augustin HG, Kuner R.
Cancer Cell 27(6):780-96. doi: 10.1016/j.ccell.2015.04.017. Erratum in: Cancer Cell. 2015 Aug 10;28(2):270. 2015
7FLT1, VEGFA
Angiogenic and Antiangiogenic Factors in Preterm Neonates Born to Mothers with and without Preeclampsia.
Hentges CR, Silveira RC, Procianoy RS.
Am J Perinatol 32(12):1185-90. doi: 10.1055/s-0035-1552932. Epub 2015 May 22. 2015
8CCNA1, FLT1
Cyclin A1 regulates the interactions between mouse haematopoietic stem and progenitor cells and their niches.
Miftakhova R, Hedblom A, Batkiewicz L, Anagnosaki L, Zhang Y, Sjölander A, Wingren AG, Wolgemuth DJ, Persson JL.
Cell Cycle 14(12):1948-60. doi: 10.1080/15384101.2015.1026513. 2015
9FLT1
Prediction of Fetal Growth Restriction by Analyzing the Messenger RNAs of Angiogenic Factor in the Plasma of Pregnant Women.
Takenaka S, Ventura W, Sterrantino AF, Kawashima A, Koide K, Hori K, Farina A, Sekizawa A.
Reprod Sci 22(6):743-9. doi: 10.1177/1933719114557895. Epub 2014 Dec 9. 2015
10FLT1
N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain.
Raikwar NS, Liu KZ, Thomas CP.
PLoS One 9(11):e112794. doi: 10.1371/journal.pone.0112794. eCollection 2014. 2014
11FLT1
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications.
Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, Dhal S, Agrawal R, Sutton RE, Druzin ML, Gambhir SS, Ambati BK, Cross JC, Nayak NR.
J Clin Invest 124(11):4941-52. doi: 10.1172/JCI76864. Epub 2014 Oct 20. 2014
12FLT1
Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy.
Zhai YL, Zhu L, Shi SF, Liu LJ, Lv JC, Zhang H.
PLoS One 9(7):e101779. doi: 10.1371/journal.pone.0101779. eCollection 2014. 2014
13FLT1, LGALS1, NRP1
Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex.
Wu MH, Ying NW, Hong TM, Chiang WF, Lin YT, Chen YL.
Angiogenesis 17(4):839-49. doi: 10.1007/s10456-014-9431-8. Epub 2014 Apr 10. 2014
14FLT1
SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice.
Amraoui F, Spijkers L, Hassani Lahsinoui H, Vogt L, van der Post J, Peters S, Afink G, Ris-Stalpers C, van den Born BJ.
PLoS One 9(3):e91897. doi: 10.1371/journal.pone.0091897. eCollection 2014. 2014
15FLT1, PGF
Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential.
d'Audigier C, Gautier B, Yon A, Alili JM, Guérin CL, Evrard SM, Godier A, Haviari S, Reille-Serroussi M, Huguenot F, Dizier B, Inguimbert N, Borgel D, Bièche I, Boisson-Vidal C, Roncal C, Carmeliet P, Vidal M, Gaussem P, Smadja DM.
Angiogenesis 17(3):603-16. doi: 10.1007/s10456-013-9413-2. Epub 2014 Jan 14. 2014
16FLT1, KDR, VEGFA
The role of VEGF and its receptors in the etiology of early pregnancy loss.
Cöl-Madendag I, Madendag Y, Altinkaya SÖ, Bayramoglu H, Danisman N.
Gynecol Endocrinol 30(2):153-6. doi: 10.3109/09513590.2013.864272. Epub 2013 Dec 4. 2014
17FLT1, MAML2
MAML2 rearrangement in primary pulmonary mucoepidermoid carcinoma and the correlation with FLT1 expression.
Zhu F, Wang W, Hou Y, Shi J, Liu Z, He D, Bai C, Li S, Jiang L.
PLoS One 9(4):e94399. doi: 10.1371/journal.pone.0094399. eCollection 2014. 2014
18FLT1, PPP3R1
Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair.
Stefater JA 3rd, Rao S, Bezold K, Aplin AC, Nicosia RF, Pollard JW, Ferrara N, Lang RA.
Blood 121(13):2574-8. doi: 10.1182/blood-2012-06-434621. Epub 2013 Jan 9. Erratum in: Blood. 2013 Sep 26;122(13):2290. 2013
19FLT1, PGF
Presymptomatic prediction of preeclampsia with angiogenic factors, in high risk pregnant women.
Teixeira PG, Reis ZS, Andrade SP, Rezende CA, Lage EM, Velloso EP, Santana CA, Cabral AC.
Hypertens Pregnancy 32(3):312-20. doi: 10.3109/10641955.2013.807818. 2013
20FLT1, VEGFB
The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A, Leppänen VM, Tvorogov D, Zarkada G, Jeltsch M, Holopainen T, Kaijalainen S, Alitalo K.
Sci Signal 6(282):ra52. doi: 10.1126/scisignal.2003905. 2013
21FLT1
Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation.
Kameda R, Yamaoka-Tojo M, Makino A, Wakaume K, Nemoto S, Kitasato L, Shimohama T, Tojo T, Machida Y, Izumi T.
Int Heart J 54(3):133-9. 2013
22FLT1, VEGFA
VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.
Saito T, Takeda N, Amiya E, Nakao T, Abe H, Semba H, Soma K, Koyama K, Hosoya Y, Imai Y, Isagawa T, Watanabe M, Manabe I, Komuro I, Nagai R, Maemura K.
FEBS Lett 587(14):2179-85. doi: 10.1016/j.febslet.2013.05.038. Epub 2013 May 24. 2013
23FLT1
Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.
Shibuya M.
J Biochem 153(1):13-9. doi: 10.1093/jb/mvs136. Epub 2012 Nov 21. Review. 2013
24FLT1, TCF21
Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function.
Jin J, Sison K, Li C, Tian R, Wnuk M, Sung HK, Jeansson M, Zhang C, Tucholska M, Jones N, Kerjaschki D, Shibuya M, Fantus IG, Nagy A, Gerber HP, Ferrara N, Pawson T, Quaggin SE.
Cell 151(2):384-99. doi: 10.1016/j.cell.2012.08.037. 2012
25FLT1, KDR, VEGFA
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.
Cudmore MJ, Hewett PW, Ahmad S, Wang KQ, Cai M, Al-Ani B, Fujisawa T, Ma B, Sissaoui S, Ramma W, Miller MR, Newby DE, Gu Y, Barleon B, Weich H, Ahmed A.
Nat Commun 3:972. doi: 10.1038/ncomms1977. 2012
26FLT1, KDR
Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice.
Ho VC, Duan LJ, Cronin C, Liang BT, Fong GH.
Circulation 126(6):741-52. doi: 10.1161/CIRCULATIONAHA.112.091603. Epub 2012 Jun 29. 2012
27FLT1
Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients.
Anand A, Gupta PK, Sharma NK, Prabhakar S.
Eur J Neurol 19(5):788-92. doi: 10.1111/j.1468-1331.2011.03548.x. Epub 2011 Oct 7. 2012
28FLT1, ROBO4, SCARB1
Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function.
Jin J, Sison K, Li C, Tian R, Wnuk M, Sung HK, Jeansson M, Zhang C, Tucholska M, Jones N, Kerjaschki D, Shibuya M, Fantus IG, Nagy A, Gerber HP, Ferrara N, Pawson T, Quaggin SE.
Cell 151(2):384-99. doi: 10.1016/j.cell.2012.08.037. 2012
29FLT1, PTK7
Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway.
Lee HK, Chauhan SK, Kay E, Dana R.
Blood lood. 2011 Apr 1. [Epub ahead of print] 2011
30FLT1, KDR, VEGFA
Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells.
Ulyatt C, Walker J, Ponnambalam S.
Biochem Biophys Res Commun 404(3):774-9. Epub 2010 Dec 17. 2011
31FLT1, RACK1
RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway.
Wang F, Yamauchi M, Muramatsu M, Osawa T, Tsuchida R, Shibuya M.
J Biol Chem 286(11):9097-106. Epub 2011 Jan 6. 2011
32FLT1, JMJD6, U2AF2
Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1.
Boeckel JN, Guarani V, Koyanagi M, Roexe T, Lengeling A, Schermuly RT, Gellert P, Braun T, Zeiher A, Dimmeler S.
Proc Natl Acad Sci U S A 108(8):3276-81. Epub 2011 Feb 7. 2011
33FLT1
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY, Schatton T, Kim S, Zhan Q, Wilson BJ, Ma J, Saab KR, Osherov V, Widlund HR, Gasser M, Waaga-Gasser AM, Kupper TS, Murphy GF, Frank MH.
Cancer Res 71(4):1474-85. Epub 2011 Jan 6. 2011
34FLT1
Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells.
Stefater JA 3rd, Lewkowich I, Rao S, Mariggi G, Carpenter AC, Burr AR, Fan J, Ajima R, Molkentin JD, Williams BO, Wills-Karp M, Pollard JW, Yamaguchi T, Ferrara N, Gerhardt H, Lang RA.
Nature 474(7352):511-5. doi: 10.1038/nature10085. 2011
35AGT, FLT1, SYK
Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.
Buharalioglu CK, Song CY, Yaghini FA, Ghafoor HU, Motiwala M, Adris T, Estes AM, Malik KU.
Am J Physiol Heart Circ Physiol 301(3):H1043-55. doi: 10.1152/ajpheart.01018.2010. Epub 2011 Jun 3. 2011
36ENG, FLT1, PGF
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, Cotton DB, Sorokin Y, Karumanchi SA.
Am J Obstet Gynecol m J Obstet Gynecol. 2010 Nov 8. [Epub ahead of print]PMID: 21062661 2010
37FLT1, KDR, VEGF1
Production of VEGF receptor 1 and 2 mRNA and protein during endochondral bone repair is differential and healing phase specific.
Reumann MK, Nair T, Strachna O, Boskey AL, Mayer-Kuckuk P.
J Appl Physiol 109(6):1930-8. Epub 2010 Oct 14. 2010
38FLT1
Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice.
Verma M, Asakura Y, Hirai H, Watanabe S, Tastad C, Fong GH, Ema M, Call JA, Lowe DA, Asakura A.
Hum Mol Genet 19(21):4145-59. Epub 2010 Aug 12. 2010
39FLT1, KDR
Expression of vascular endothelial growth factor receptor-1/-2 and nitric oxide in unruptured intracranial aneurysms.
Maderna E, Corsini E, Franzini A, Giombini S, Pollo B, Broggi G, Solero CL, Ferroli P, Messina G, Marras C.
Neurol Sci 31(5):617-23. Epub 2010 Jul 16. 2010
40FLT1
Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose.
Nandy D, Mukhopadhyay D, Basu A.
J Investig Med 58(6):804-6. 2010
41FLT1, KDR
Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment.
Lorquet S, Berndt S, Blacher S, Gengoux E, Peulen O, Maquoi E, Noël A, Foidart JM, Munaut C, Péqueux C.
FASEB J 24(10):3782-95. Epub 2010 May 19. 2010
42FLT1, KDR
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nör JE.
Cell Death Differ 17(3):499-512. Epub 2009 Oct 16. 2010
43FLT1, RAB4A
VEGFR1 (Flt1) regulates Rab4 recycling to control fibronectin polymerization and endothelial vessel branching.
Jones MC, Caswell PT, Moran-Jones K, Roberts M, Barry ST, Gampel A, Mellor H, Norman JC.
Traffic 10(6):754-66.PMID: 19302266 2009
44FLT1, PGF
Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, Cho CS, Kim WU.
Arthritis Rheum 60(2):345-54. 2009
45FLT1, KDR, TEK, TIE1
Expression of VEGF receptors VEFGR-1 and VEGFR-2, angiopoietin receptors Tie-1 and Tie-2 in chorionic villi tree during early pregnancy.
Demir R.
Folia Histochem Cytobiol 47(3):435-45. 2009
46ANTXR1, FLT1, KDR
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma.
Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR.
Nat Med 14(11):1236-46. Epub 2008 Oct 19. 2008
47CTNNAL1, FLT1, GSTP1, LEP, PAPPA2, S100A8, WWTR1
Seven placental transcripts characterize HELLP-syndrome.
Buimer M, Keijser R, Jebbink JM, Wehkamp D, van Kampen AH, Boer K, van der Post JA, Ris-Stalpers C.
Placenta 29(5):444-53. 2008
48FLT1, VEGFA
The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer.
Takenaka K, Katakura H, Chen F, Ogawa E, Adachi M, Wada H, Tanaka F.
Cancer Lett 246(1-2):34-40. Epub 2006 Mar 10. 2007
49FLT1
Corneal avascularity is due to soluble VEGF receptor-1.
Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J.
Nature 443(7114):993-7. Epub 2006 Oct 18. 2006
50FLT1
Interleukin-1beta regulates vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts.
Nasu K, Itoh H, Yuge A, Kawano Y, Yoshimatsu J, Narahara H.
Gynecol Endocrinol 22(9):495-500. 2006
51FLT1
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases.
Lesslie DP, Summy JM, Parikh NU, Fan F, Trevino JG, Sawyer TK, Metcalf CA, Shakespeare WC, Hicklin DJ, Ellis LM, Gallick GE.
Br J Cancer 94(11):1710-7. 2006
52FLT1, KDR
Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.
Amaoka N, Saio M, Nonaka K, Imai H, Tomita H, Sakashita F, Takahashi T, Sugiyama Y, Takami T, Adachi Y.
Oncol Rep 16(1):3-10. 2006
53FIGF, FLT1, FLT4, KDR, NRP1, NRP2, PGF, VEGFA, VEGFB, VEGFC
Biology of vascular endothelial growth factors.
Roy H, Bhardwaj S, YlŠ-Herttuala S.
FEBS Lett 580(12):2879-87. Epub 2006 Apr 17. 2006
54FLT1,KDR
Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
Kou R, SenBanerjee S, Jain MK, Michel T.
Biochemistry 44(45):15064-73. 2005
55FLT1, KDR, PGF, VEGFA
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.
Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P.
Nat Med 9(7):936-43. 2003
56BVES, FLT1, PAX3
Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.
Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB.
Genomics 79(3):278-84. 2002
57FLT1
Identification of functional VEGF receptors on human platelets.
Selheim F, Holmsen H, Vassbotn FS.
FEBS Lett 512(1-3):107-10. 2002
58FLT1
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE, Bone ND, Tschumper RC, Howell KH, Geyer SM, Dewald GW, Hanson CA, Jelinek DF.
Leukemia 16(5):911-9. 2002
59FLT1
Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells.
Tsou R, Isik FF.
Mol Cell Biochem 224(1-2):81-9. 2001
60FLT1
Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors.
Barleon B, Reusch P, Totzke F, Herzog C, Keck C, Martiny-Baron G, Marme D.
Angiogenesis 4(2):143-54. 2001
61FLT1, KDR
A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.
Gille H, Kowalski J, Yu L, Chen H, Pisabarro MT, Davis-Smyth T, Ferrara N.
EMBO J 19(15):4064-4073. 2000
62FLT1
Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16.
Inoue T, Kibata K, Suzuki M, Nakamura S, Motoda R, Orita K.
FEBS Lett 469(1):14-8. 2000
63FIGF, FLT1, FLT4, KDR, VEGFA, VEGFB, VEGFC
Vascular endothelial growth factor and its receptors.
Klagsbrun M, D'Amore PA.
Cytokine Growth Factor Rev 7(3):259-70. Review. 1996
64FLT1
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC.
Nature 376(6535):62-6. 1995
65FLT1, FLT3
Characterization of a yeast artificial chromosome from human chromosome band 13q12 containing the FLT1 and FLT3 receptor-type tyrosine kinase genes.
Imbert A, Rosnet O, Marchetto S, Ollendorff V, Birnbaum D, Pebusque MJ.
Cytogenet Cell Genet 67(3):175-7. 1994
66FLT1
Dinucleotide repeat polymorphism in the 3' non-coding region of the FLTI gene.
Han HJ, Fujiwara T, Shin S, Nakamura Y.
Hum Mol Genet 2(12):2204. 1993
67FLT1
Assignment of four sequence-tagged sites to three subregions of 13q12 using a somatic cell hybrid mapping panel.
Michalski AJ, Cowell JK.
Genomics 18(1):141-3. 1993
68FLT1, FLT3
Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse.
Rosnet O, Stephenson D, Mattei MG, Marchetto S, Shibuya M, Chapman VM, Birnbaum D.
Oncogene 8(1):173-9. 1993
69FLT1
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
Kendall RL, Thomas KA.
Proc Natl Acad Sci U S A 90(22):10705-9. 1993
70FLT1
Dinucleotide repeat polymorphism at the human fms-related tyrosine kinase gene (FLT1).
Polymeropoulos MH, Rath DS, Xiao H, Merril CR.
Nucleic Acids Res 19(10):2803. 1991
71FLT1, KDR
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M.
Oncogene 5(4):519-24. 1990
72FLT1, ROS1
Two ros-related protooncogenes, c-ros-1 and flt, are regionally mapped on human chromosomes 6q22 and 13q12, respectively.
Yoshida MC, et al.
(HGM9) Cytogenet Cell Genet 46 : 724. 1987
73FLT1, ROS1
Regional localization of the human c-ros-1 on 6q22 and flt on 13q12.
Satoh H, Yoshida MC, Matsushime H, Shibuya M, Sasaki M.
Jpn J Cancer Res 78(8):772-5. 1987